ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of Paliperidone in Schizophrenia - Bangladesh Study
This is a single-arm, open-label, multicenter, prospective quasi-experimental study evaluating the efficacy and safety of extended-release paliperidone in adults with schizophrenia in Bangladesh. The study will assess psychotic symptom improvement using the PANSS scale, monitor side effects using GASS, and evaluate quality of life via WHOQOL-BREF.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Theory Based Integrated Program on Medication Adherence Among Community Dwelling Schizophrenia#1185978
- Safety and Efficacy of MP-214 in Patients With Schizophrenia#871436
- Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole#910219
- Aripiprazole Oral Acceptability Trial#841287
- Baseline clinical characterization of participants in the Accelerating Medicines Partnership Schizophrenia Program#431640
Record · ID 1407152
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive